Ryan A. Seth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ryan A. Seth has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Adam Calaway
Department of Urology, Case Western Reserve University, Cleveland, Ohio
1 shared publication Alecia B. Rokes
Department of Biological Sciences, Lehigh University, Bethlehem, Pennsylvania, USA
1 shared publicationAlexa A. Alhout
Department of Biological Sciences, Lehigh University, Bethlehem, Pennsylvania, USA
1 shared publicationBrianna Gipson
Department of Biological Sciences, Lehigh University, Bethlehem, Pennsylvania, USA
1 shared publicationBrooke P. Lichak
Department of Biological Sciences, Lehigh University, Bethlehem, Pennsylvania, USA
1 shared publicationCaitlin E. Murphy
Department of Biological Sciences, Lehigh University, Bethlehem, Pennsylvania, USA
1 shared publication
Latest Publications
- 1 April 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (1) , e252547
Characterization of Clinically Significant Prostate Cancer in the Peripheral Zone Using Rapid B 1 -Insensitive MR Fingerprinting
Quantitative MRI evaluation of prostate lesions using rapid, B 1 -insensitive prostate MR fingerprinting and apparent diffusion coefficient mapping differentiated clinically significant cancers from clinically insignificant lesions.
- 1 April 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (1) , e252547
Characterization of Clinically Significant Prostate Cancer in the Peripheral Zone Using Rapid B 1 -Insensitive MR Fingerprinting
Quantitative MRI evaluation of prostate lesions using rapid, B 1 -insensitive prostate MR fingerprinting and apparent diffusion coefficient mapping differentiated clinically significant cancers from clinically insignificant lesions.
- 1 September 2024
- Published by Wolters Kluwer Health in Urology Practice
- Vol. 11 (5) , 789
Editorial Commentary
- 1 September 2024
- Published by Wolters Kluwer Health in Urology Practice
- Vol. 11 (5) , 789
Editorial Commentary
- 10 December 2021
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 322 (1) , H87-H93
Contribution of the von Willebrand factor/ADAMTS13 imbalance to COVID-19 coagulopathy
The 2019 coronavirus disease (COVID-19) is the disease caused by SARS-CoV-2 infection. Although this infection has been shown to affect the respiratory system, a high incidence of thrombotic events has been observed in severe cases of COVID-19 and in a significant portion of COVID-19 nonsurvivors. Although prior literature has reported on both the coagulopathy and hypercoagulability of COVID-19, the specifics of coagulation have not been fully investigated. Observations of microthrombosis in patients with COVID-19 have brought attention to potential inflammatory endothelial injury. Von Willebrand factor (VWF) and its protease, A disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13), play an important homeostatic role in responding to endothelial injury. This report provides an overview of the literature investigating the role the VWF/ADAMTS13 axis may have in COVID-19 thrombotic events and suggests potential therapeutic strategies to prevent the progression of coagulopathy in patients with COVID-19.
- 10 December 2021
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 322 (1) , H87-H93
Contribution of the von Willebrand factor/ADAMTS13 imbalance to COVID-19 coagulopathy
The 2019 coronavirus disease (COVID-19) is the disease caused by SARS-CoV-2 infection. Although this infection has been shown to affect the respiratory system, a high incidence of thrombotic events has been observed in severe cases of COVID-19 and in a significant portion of COVID-19 nonsurvivors. Although prior literature has reported on both the coagulopathy and hypercoagulability of COVID-19, the specifics of coagulation have not been fully investigated. Observations of microthrombosis in patients with COVID-19 have brought attention to potential inflammatory endothelial injury. Von Willebrand factor (VWF) and its protease, A disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13), play an important homeostatic role in responding to endothelial injury. This report provides an overview of the literature investigating the role the VWF/ADAMTS13 axis may have in COVID-19 thrombotic events and suggests potential therapeutic strategies to prevent the progression of coagulopathy in patients with COVID-19.
- Open Access
- 30 May 2019
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 8 (22) , e00399-19
Genome Sequences of Six Cluster N Mycobacteriophages, Kevin1, Nenae, Parmesanjohn, ShrimpFriedEgg, Smurph, and SpongeBob, Isolated on Mycobacterium smegmatis mc 2 155
The annotation of six cluster N Mycobacterium smegmatis phages (Kevin1, Nenae, Parmesanjohn, ShrimpFriedEgg, Smurph, and SpongeBob) reveals regions of genomic diversity, particularly within the central region of the genome. The genome of Kevin1 includes two orphams (genes with no similarity to other phage genes), with one predicted to encode an AAA-ATPase.
- 30 May 2019
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 8 (22) , e00399-19
Open AccessGenome Sequences of Six Cluster N Mycobacteriophages, Kevin1, Nenae, Parmesanjohn, ShrimpFriedEgg, Smurph, and SpongeBob, Isolated on Mycobacterium smegmatis mc 2 155
The annotation of six cluster N Mycobacterium smegmatis phages (Kevin1, Nenae, Parmesanjohn, ShrimpFriedEgg, Smurph, and SpongeBob) reveals regions of genomic diversity, particularly within the central region of the genome. The genome of Kevin1 includes two orphams (genes with no similarity to other phage genes), with one predicted to encode an AAA-ATPase.